1. Home
  2. IOBT

as 09-05-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Founded: 2014 Country:
Denmark
Denmark
Employees: N/A City: COPENHAGEN
Market Cap: 114.6M IPO Year: 2021
Target Price: $8.67 AVG Volume (30 days): 8.9M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.58 EPS Growth: N/A
52 Week Low/High: $0.66 - $2.79 Next Earning Date: 08-14-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

IOBT Daily Stock ML Predictions

Share on Social Networks: